ditritiocorreolide

Known as: diTC 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BackgroundThe systemic information enclosed in microarray data encodes relevant clues to overcome the poorly understood… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2013
2013
Nowadays, oncogene-directed therapy and immunotherapy represent the two most promising avenues for patients with metastatic… (More)
Is this relevant?
2012
2012
In this paper, instantaneous torque control for switched reluctance machines (SRMs) with an arbitrary number of phases is… (More)
  • figure 3
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Instantaneous torque control for switched-reluctance-machines (SRMs) with an arbitrary number of phases is introduced in this… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 7
Is this relevant?
2003
2003
Activation of adenosine A1 or A3 receptors protects heart cells from ischemia-induced injury. The A3 receptor signals via RhoA… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
This paper presents an on-line instantaneous torque control technique. The method comprises two novel aspects. Torque is… (More)
  • figure 2
  • figure 1
  • figure 5
  • figure 3
  • figure 4
Is this relevant?
2001
2001
Correolide is a novel immunosuppressant that inhibits the voltage-gated potassium channel K(v)1.3 [Felix et al. (1999… (More)
Is this relevant?
1999
1999
Correolide, a novel nortriterpene natural product, potently inhibits the voltage-gated potassium channel, K(v)1.3, and [(3)H… (More)
Is this relevant?
1999
1999
A novel nortriterpene, termed correolide, purified from the tree Spachea correae, inhibits Kv1.3, a Shaker-type delayed rectifier… (More)
Is this relevant?
1996
1996
This study tested whether an irreversible agonist of the A1 adenosine receptor, m-DITC ADAC, can mimic the protective effect of… (More)
Is this relevant?